Molecular Biology of Hematopoiesis 6

1. The Development of Hematopoietic Cell Transplantation and Its Application to Organ Transplantation and Autoimmune Diseases.- 2. Hemopoietic Stem Cells—Normal and Abnormal.- 3. Immunity and Tolerance are Related, and Governed by Antigen Migration and Localization.- 4. Genetic Approaches to the Investigation of the Mechanisms of Hematopoietic Progenitor Cell Mobilization into the Blood.- 5. Role of Hematopoietic Growth Factors on the Ex Vivo Expansion of Primitive Cord Blood Stem Cells.- 6. Thymus-Independent T Cell Differentiation in Vitro.- 7. Immunogenetics Problems in Cord Blood Transplantation.- 8. Presence of B Cell Progenitors in the Thymus.- 9. De Novo and Secondary AML Cells Differ in their Kinetic Response to HGF Priming.- 10. Molecular Diagnosis of Philadelphia-Positive Leukemias.- 11. Differential Enhancement of Graft-versus-Host (GVH) and Graft-versus- Leukemia (GVL) Reactions by Interleukin-12 (IL-12).- 12. Expression of C-erb B-2/HER-2 in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Blood Stem Cell Support.- 13. Clinical Factors Contributing to the Pace of Engraftment after Allogeneic and Autologous Stem Cell Transplantation: Multivariate Analyses.- 14. Clinical Relevance of Bone Marrow Histologic Examination in HIV-Infected Patients.- 15. Molecular Biology of Childhood Solid Tumors: Promises Maintained and Promises Postponed.- 16. Molecular Genetics of Wilms Tumor.- 17. Genetic Heterogeneity in Ewing Tumors and Neuroblastomas.- 18. Mechanisms of Retinoid Inhibition of Cell Proliferation in Neuroblastoma.- 19. High-dose Chemotherapy for Breast Cancer in Europe: From Fashion to Randomization.- 20. Combination of Carboplatin and Etoposide in the Management of Intraocular Retinoblastoma.- 21. Hyper-IL-6 (H-IL-6),a Fusion Protein of Soluble IL-6 Receptor (SIL-6R) and Interleukin-6 (IL-6), Acts Synergistic with Thrombopoietin (TPO) and Stem Cell Factor (SCF) in Expanding Megakaryocyte Progenitors from Human CD34++/CD90+ Cell.- 22. Towards Vaccination with Defined Tumor Antigens?.- 23. Molecular Monitoring of Non-Hodgkin’s Lymphomas.- 24. Classification of Malignant Lymphomas: State of the Art.- 25. The Pathologic Spectrum of AIDS-Related Non-Hodgkin’s Lymphomas.- 26. Genesis and Progression of Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.- 27. Cytokines, Thrombopoietin, and Selectins in Immune Thrombocytopenic Purpura.- 28. Lymphocyte Fractionation in a Magnetic Flow Cell Sorter.- 29. The Basis for a Rational Nutritional Approach to Patients with Cancer.- 30. Differential Expression of IL-3 and GM-CSF Receptor Common Signal Transducing Subunit (?C) during Normal Hematopoietic Differentiation.- 31. Expression of Distal Gatal Transcripts in Erythroid Cells.- 32. Expressions of Fas (CD95) and Fas Ligand in HIV Infected Individuals.- 33. Pattern of PU.1 Binding to M-CSF Receptor Promoter during Monocyte to Macrophage Maturation.- 34. Molecular Biology of Hypoxia-Inducible Factor-1.- 35. Identification and Characterization of Constituavely Active STAT5.- 36. An Increase in the Levels of Retroviral-Mediated Transduction of Engrafting Human Hematopoietic Progenitors Can Be Obtained by Manipulation of the Hematopoietic Cell Cycle.- 37. Gene Transfer to the Nervous System Using High-Titer Retroviral Vector.- 38. Hematological Aspects of Common Marmoset Monkey Transplanted with Autologous MDR1 Gene Transduced Peripheral Blood Stem Cells.- 39. Effect of Retrovirus and Adenovirus Mediated Interferon Gene Transfer on Hematopoietic Progenitor Cell Growth.- 40.Prostaglandin’s Suppressing Effect on Bone Marrow Erythropoiesis in Rats.- 41. Hematological and Biochemical Parameters in Hereditary Spherocytosis under Oxidative Stress.- 42. Lymphocyte Populations in Hereditary Spherocytosis Pre and Post Splenectomy and under Oxidative Stress.- 43. The Hereditary Hemochromatosis Gene and Iron Homeostasis.- 44. Iron and Erythropoiesis: Lessons from Anemic Mice.- 45. Juvenile Hemochromatosis: Search for Candidate Genes.- 46. New Insights on Congenital Dyserithropoietic Anemia Type II.- 47. Iron Chelation in Cancer Therapy.- 48. Transcriptional Regulation of the Ferritin H-Chain and Transferrin Receptor in Hematopoietic Cells.